drugset / Trial / NCT06122610
Using Novel Imaging to More Safely Treat Neuroendocrine Tumors
NaSingle-groupOpen-labelTreatment
Summary
The goal of this research is to determine if DetectnetTM PET/CT can be used to make Lutathera therapy safer for patients with neuroendocrine cancer. Participants will: * Complete two phases involving 6 visits * Undergo additional research PET/CT, and possibly SPECT/CT scans
Timeline
- Start
- 2025-03-07
- Primary completion
- 2026-05-31
- Completion
- 2026-05-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | 177Lu-DOTATATE | Peptide | — | — |
| Subject | COPPER OXODOTREOTIDE | Peptide | — | — |